Results 71 to 80 of about 83,435 (304)

Pharmacotherapy of hyperthyroidism

, 2018
Overview of pharmacotherapy of hyperthyroidism.
Thorvaldsson, Alexander
core  

Tolerability of Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: A Real‐World Study

International Journal of Cancer, EarlyView.
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt, Anniek Strijdhorst, Tamara Jessica Huizer, Esther Albertien Kleibeuker, Sarah Derks, Bianca Mostert, Hanneke van Laarhoven, Jacco Juri de Haan   +7 more
wiley   +1 more source

Hypothyroidism and hyperthyroidism.

Acta bio-medica : Atenei Parmensis, 2019
Congenital hypothyroidism is a condition in which the thyroid gland does not produce enough thyroid hormones. It occurs in 1:2000-4000 newborns. Common clinical features include decreased activity and increased sleep, feeding difficulty, constipation, prolonged jaundice, myxedematous facies, large fontanels (especially posterior), macroglossia ...
Guerri, Giulia, Bressan, Simone, Sartori, Marianna, Costantini, Alisia, Benedetti, Sabrina, Agostini, Francesca, Tezzele, Silvia, Cecchin, Stefano, Scaramuzza, Andrea, Bertelli, Matteo   +9 more
openaire   +2 more sources

Diabetes Increases Immunotherapy‐Related Toxicity but Not Efficacy in Metastatic Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study

International Journal of Cancer, EarlyView.
ABSTRACT This multicenter retrospective study evaluated the impact of type 2 diabetes mellitus (DM) on clinical outcomes and immune‐related adverse events (irAEs) in 450 patients with metastatic non‐small cell lung cancer (NSCLC) treated with second‐line nivolumab at 17 centers between 2016 and 2024. Among these patients, 118 (26.2%) had DM.
Emre Çakır, Didem Divriklioğlu, Deniz Can Güven, Gamze Serin Özel, Oğuzhan Yıldız, Gamze Emin, Merve Keskinkılıç, Yeşim Ağyol, Onur Yazdan Balçık, Nagihan Kolkıran, Hale Gülçin Yıldırım Doğan, Pervin Can Şancı, Özge Yalıcı, Teoman Şakalar, Yurdagül Danacı, Yakup Düzköprü, Canan Yıldız, Mesut Yılmaz, İlhan Hacıbekiroğlu, Bülent Erdoğan, Saadettin Kılıçkap, Gamze Gököz Doğu, Melek Karakurt Eryılmaz, Atila Yıldırım, İlhan Öztop, İbrahim Vedat Bayoğlu, Şahnura Uzuntaş, Atike Pınar Erdoğan, Emir Çelik, Devrim Çabuk, Erdoğan Selçuk Şeber, Zehra Sadak Öcal, Hacer Demir   +32 more
wiley   +1 more source

Monitoring thyroid function status in elderly patients on amiodarone [PDF]

, 2006
Objectives: To evaluate whether elderly patients on amiodarone were having their thyroid function status monitored as recommended in the literature and to identify the frequency and type of thyroid function test abnormalities noted.
Fiorini, Anthony
core  

Hyperdynamic right heart function in Graves’ hyperthyroidism measured by echocardiography normalises on restoration of euthyroidism

, 2017
Background: Graves’ hyperthyroidism commonly causes tachycardia and may result in pulmonary hypertension and high output cardiac failure. There is limited information regarding the effect of treatment on cardiac function measured using modern ...
Teasdale, SL, Stowasser, M, Stanton, T, Inder, WJ   +3 more
core   +1 more source

Incidence and Predictors of Immune‐Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real‐World Cohort Study

International Journal of Cancer, EarlyView.
ABSTRACT Immune checkpoint inhibitors (ICIs) frequently cause thyroid immune‐related adverse events (irAEs). Permanent hypothyroidism, the clinically most relevant phenotype, requires lifelong hormone replacement. We investigated its incidence, course, risk factors, and prognostic relevance under pembrolizumab.
Freya Koffka, Johann Kornowski, Elena Laakmann, Barbara Schmalfeldt, Tim Zell, Glenn Geidel, Christoffer Gebhardt, Pia Roser, Volkmar Müller, Julian Kött   +9 more
wiley   +1 more source

Abnormal QT Dispersion in Hyperthyroidism

Endocrinology Research and Practice, 2022
Cardiac symptoms have a prominent position in hyperthyroidism. The cardiac and non-cardiac symptoms of hyperthyroidism may in part be related to an Increased sympathoadrenal activity. The thyroid hormones also exert a direct effect on the heart.
Berrin Çetinarslan, Özhan Güldeli, Dilek Ural, Ayşe Çefle, Ayşen Ağaçdiken, Baki Komşuoğlu   +5 more
doaj   +2 more sources

Betaxolol Versus Propranolol for the Control of Tachycardia of Hyperthyroidism

, 2008
Objective: Betaxolol is a long-acting highly selective β- blocker. To the best of our knowledge, there has been no report about the use of betaxolol in hyperthyroidism.
CHANG, YING-CHUN;SU, DENG-HUANG;CHANG, TIEN-CHUN, 張英俊;蘇登煌;張天鈞   +1 more
core  

Association between maternal pre‐pregnancy body mass index and maternal and neonatal outcomes in Saudi Arabia: A retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective The body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters) of the mother before pregnancy and the growth of weight during pregnancy are both important perinatal health determinants. The aim of the present study was to examine the association between the maternal BMI and obstetric and ...
Randa Elsayed, Eman Al Ali, Rawabi AlAbdulgader, Shouq ALshuwayfie, Hasna Almutawa, Zahra Alhawaj, Bayan Albesher, Fatimah Almuaybid   +7 more
wiley   +1 more source